• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: HOLOGIC, INC. APTIMA SARS COV-2; REAGENTS, 2019-NOVEL CORONAVIRUS NUCLEIC ACID

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

HOLOGIC, INC. APTIMA SARS COV-2; REAGENTS, 2019-NOVEL CORONAVIRUS NUCLEIC ACID Back to Search Results
Catalog Number PRD-06419
Device Problem Device Contaminated at the User Facility (4064)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 09/08/2022
Event Type  malfunction  
Event Description
Customer reported positive contamination on two of their panther instruments, panther fusion sn (b)(4) and panther sn (b)(4), during monthly environmental swab testing.Swabs which should have resulted negative had low positive results instead, indicative of instrument contamination.Customer stated their panther instruments were used for sars-cov-2 testing but did not specify which sars-cov-2 assay was used/affected at this time.Hologic contacted customer multiple times but could not reach them to obtain further information such as affected assay lots, worklists, or sample ids.The information provided by the customer was insufficient to characterize any sample as a confirmed false result.Hologic confirmed that customer did not report out positive results during the affected period without confirming their validity on another platform.There were no associated/reported adverse events or patient impact reported.
 
Manufacturer Narrative
Customer performed a deep-clean monthly maintenance, including sample shields, racks, reagent and sample preparation areas, but issue persisted.Customer performed a second decontamination, which resolved the issue and generated valid results.Hologic technical support and applications specialists attempted to obtain more information multiple times from customer, but they were unresponsive.No further investigation or troubleshooting could be completed, but no further issues were reported.As part of eua agreement, fda requires all aptima sars-cov-2 assay questioning results and false results (confirmed or not) complaints to be reported as malfunction mdr.Device evaluated by mfr: other.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
APTIMA SARS COV-2
Type of Device
REAGENTS, 2019-NOVEL CORONAVIRUS NUCLEIC ACID
Manufacturer (Section D)
HOLOGIC, INC.
10210 genetic center drive
san diego CA 92121
Manufacturer (Section G)
HOLOGIC, INC.
10210 genetic center drive
san diego CA 92121
Manufacturer Contact
kyleigh jacobs
10210 genetic center drive
san diego, CA 92121
8584108566
MDR Report Key15537394
MDR Text Key301837969
Report Number2024800-2022-01095
Device Sequence Number1
Product Code QJR
Combination Product (y/n)N
Reporter Country CodeUK
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 10/04/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/04/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Catalogue NumberPRD-06419
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received09/08/2022
Was Device Evaluated by Manufacturer? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage A
Patient Sequence Number1
-
-